Alignment Healthcare, Inc. (NASDAQ:ALHC) Receives $24.60 Average Target Price from Brokerages

Alignment Healthcare, Inc. (NASDAQ:ALHC) has received a consensus recommendation of “Moderate Buy” from the eleven research firms that are covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation, six have given a buy recommendation and two have issued a strong buy recommendation on the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $24.60.

A number of brokerages have recently issued reports on ALHC. Weiss Ratings upgraded Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a report on Thursday, May 7th. JPMorgan Chase & Co. upped their target price on Alignment Healthcare from $23.00 to $26.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Robert W. Baird set a $28.00 target price on Alignment Healthcare in a research report on Friday, January 30th. Wolfe Research began coverage on Alignment Healthcare in a research report on Friday, April 17th. They issued an “outperform” rating and a $24.00 target price on the stock. Finally, KeyCorp reaffirmed an “overweight” rating and issued a $28.00 target price on shares of Alignment Healthcare in a research report on Thursday, January 22nd.

Insider Buying and Selling at Alignment Healthcare

In related news, insider Andreas P. Wagner sold 11,602 shares of the company’s stock in a transaction that occurred on Thursday, March 19th. The stock was sold at an average price of $18.22, for a total transaction of $211,388.44. Following the sale, the insider directly owned 148,628 shares of the company’s stock, valued at approximately $2,708,002.16. This represents a 7.24% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, President Dawn Christine Maroney sold 30,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 15th. The shares were sold at an average price of $20.87, for a total value of $626,100.00. Following the sale, the president directly owned 1,028,813 shares in the company, valued at approximately $21,471,327.31. This represents a 2.83% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 1,539,859 shares of company stock worth $28,950,458. 5.20% of the stock is owned by insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Summit Securities Group LLC bought a new position in Alignment Healthcare during the fourth quarter valued at about $26,000. Parallel Advisors LLC lifted its stake in Alignment Healthcare by 87.7% in the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after acquiring an additional 773 shares in the last quarter. Larson Financial Group LLC purchased a new stake in Alignment Healthcare in the 3rd quarter worth about $33,000. First Horizon Corp purchased a new stake in Alignment Healthcare in the 4th quarter worth about $39,000. Finally, GAMMA Investing LLC lifted its stake in Alignment Healthcare by 83.8% in the 4th quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock worth $43,000 after acquiring an additional 987 shares in the last quarter. Institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Stock Up 3.5%

ALHC opened at $16.28 on Thursday. The company has a debt-to-equity ratio of 1.56, a current ratio of 1.58 and a quick ratio of 1.58. The stock has a market capitalization of $3.37 billion, a price-to-earnings ratio of 180.89, a price-to-earnings-growth ratio of 2.20 and a beta of 1.26. The business has a 50-day moving average of $18.98 and a two-hundred day moving average of $19.45. Alignment Healthcare has a 12 month low of $11.63 and a 12 month high of $23.87.

Alignment Healthcare (NASDAQ:ALHC) last issued its earnings results on Thursday, April 30th. The company reported $0.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.01 by $0.04. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.The business had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.22 billion. During the same quarter in the previous year, the business earned ($0.05) EPS. The company’s revenue for the quarter was up 33.3% on a year-over-year basis. On average, research analysts expect that Alignment Healthcare will post 0.19 earnings per share for the current year.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.